ACRUX Ltd (ACR) - Total Liabilities

Latest as of June 2025: AU$6.20 Million AUD ≈ $4.39 Million USD

Based on the latest financial reports, ACRUX Ltd (ACR) has total liabilities worth AU$6.20 Million AUD (≈ $4.39 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of ACRUX Ltd to track the company's year-over-year net asset growth rate.

ACRUX Ltd - Total Liabilities Trend (2001–2025)

This chart illustrates how ACRUX Ltd's total liabilities have evolved over time, based on quarterly financial data. See ACRUX Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

ACRUX Ltd Competitors by Total Liabilities

The table below lists competitors of ACRUX Ltd ranked by their total liabilities.

Company Country Total Liabilities
Iterum Therapeutics PLC
NASDAQ:ITRM
USA $39.88 Million
8I Holdings Ltd
AU:8IH
Australia AU$316.61K
Playfair Mining Ltd.
V:PLY
Canada CA$83.06K
Nevada Sunrise Gold Corp
V:NEV
Canada CA$129.67K
EQTEC plc
LSE:EQT
UK £9.22 Million
Card Factory PLC
LSE:CARD
UK GBX300.10 Million
Capstone Holding Corp. Common Stock
NASDAQ:CAPS
USA $42.57 Million
Inomin Mines Inc
V:MINE
Canada CA$1.56 Million

Liability Composition Analysis (2001–2025)

This chart breaks down ACRUX Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ACR market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.07 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.19 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 6.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.86 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ACRUX Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ACRUX Ltd (2001–2025)

The table below shows the annual total liabilities of ACRUX Ltd from 2001 to 2025.

Year Total Liabilities Change
2025-06-30 AU$6.20 Million
≈ $4.39 Million
+9.06%
2024-06-30 AU$5.69 Million
≈ $4.02 Million
+1.50%
2023-06-30 AU$5.60 Million
≈ $3.96 Million
-9.38%
2022-06-30 AU$6.18 Million
≈ $4.37 Million
+7.89%
2021-06-30 AU$5.73 Million
≈ $4.06 Million
+1.04%
2020-06-30 AU$5.67 Million
≈ $4.01 Million
+127.15%
2019-06-30 AU$2.50 Million
≈ $1.77 Million
-0.87%
2018-06-30 AU$2.52 Million
≈ $1.78 Million
-25.50%
2017-06-30 AU$3.38 Million
≈ $2.39 Million
-64.34%
2016-06-30 AU$9.48 Million
≈ $6.71 Million
+20.48%
2015-06-30 AU$7.87 Million
≈ $5.57 Million
-29.51%
2014-06-30 AU$11.16 Million
≈ $7.90 Million
+81.76%
2013-06-30 AU$6.14 Million
≈ $4.35 Million
+13.83%
2012-06-30 AU$5.40 Million
≈ $3.82 Million
-59.38%
2011-06-30 AU$13.28 Million
≈ $9.40 Million
+323.57%
2010-06-30 AU$3.14 Million
≈ $2.22 Million
-15.86%
2009-06-30 AU$3.73 Million
≈ $2.64 Million
+18.02%
2008-06-30 AU$3.16 Million
≈ $2.23 Million
+48.75%
2007-06-30 AU$2.12 Million
≈ $1.50 Million
-19.92%
2006-06-30 AU$2.65 Million
≈ $1.88 Million
+64.47%
2005-06-30 AU$1.61 Million
≈ $1.14 Million
+19.52%
2004-06-30 AU$1.35 Million
≈ $954.23K
+14.18%
2003-06-30 AU$1.18 Million
≈ $835.75K
+35.69%
2002-06-30 AU$870.46K
≈ $615.91K
+17.47%
2001-06-30 AU$741.00K
≈ $524.30K
--

About ACRUX Ltd

AU:ACR Australia Biotechnology
Market Cap
$3.20 Million
AU$4.52 Million AUD
Market Cap Rank
#29352 Global
#1653 in Australia
Share Price
AU$0.01
Change (1 day)
+10.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.83
About

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more